Irisin Inhibits Atherosclerosis by Promoting Endothelial Proliferation Through microRNA126‐5p

Background Irisin is a newly discovered myokine that has been considered a promising candidate for the treatment of cardiovascular disease through improving endothelial function. However, little is known about the role of irisin in the progression of atherosclerosis. Methods and Results We used a carotid partial ligation model of apolipoprotein E–deficient mice fed on a high‐cholesterol diet to test the anti‐atherosclerosis effect of irisin. Irisin treatment significantly suppressed carotid neointima formation. It was associated with increased endothelial cell proliferation. In addition, irisin promoted human umbilical vein endothelial cell survival via upregulating microRNA126‐5p expression through the ERK signaling pathway. Inhibition of microRNA126‐5p using the microRNA126‐5p inhibitor abolished the prosurvival effect. The same results were demonstrated in vivo as the expression of microRNA126‐5p noticeably increased in ligated carotid artery after irisin treatment. Furthermore, in vivo blockade of microRNA126‐5p expression using the antagomir abolished the inhibitory effects of irisin on neointima formation, lesional lipid deposition, macrophage area, and the pro‐proliferation effects on endothelial cells. Conclusions Taken together, our study demonstrates that irisin significantly reduces atherosclerosis in apolipoprotein E–deficient mice via promoting endothelial cell proliferation through microRNA126‐5p, which may have a direct therapeutic effect on atherosclerotic diseases.

[1]  F. Wang,et al.  Protective Effect of Irisin on Atherosclerosis via Suppressing Oxidized Low Density Lipoprotein Induced Vascular Inflammation and Endothelial Dysfunction , 2016, PloS one.

[2]  R. Cheng,et al.  Irisin promotes osteoblast proliferation and differentiation via activating the MAP kinase signaling pathways , 2016, Scientific Reports.

[3]  F. Wang,et al.  Irisin relaxes mouse mesenteric arteries through endothelium-dependent and endothelium-independent mechanisms. , 2015, Biochemical and biophysical research communications.

[4]  Yigang Li,et al.  The role of miR-19b in the inhibition of endothelial cell apoptosis and its relationship with coronary artery disease , 2015, Scientific Reports.

[5]  B. Spiegelman,et al.  Detection and Quantitation of Circulating Human Irisin by Tandem Mass Spectrometry. , 2015, Cell metabolism.

[6]  Haichang Wang,et al.  Irisin improves endothelial function in type 2 diabetes through reducing oxidative/nitrative stresses. , 2015, Journal of molecular and cellular cardiology.

[7]  Xiaodong Sun,et al.  Irisin improves endothelial function in obese mice through the AMPK-eNOS pathway. , 2015, American journal of physiology. Heart and circulatory physiology.

[8]  Xiaodong Sun,et al.  The relationship between circulating irisin levels and endothelial function in lean and obese subjects , 2015, Clinical endocrinology.

[9]  Yuan Zhang,et al.  Irisin Induces Angiogenesis in Human Umbilical Vein Endothelial Cells In Vitro and in Zebrafish Embryos In Vivo via Activation of the ERK Signaling Pathway , 2015, PloS one.

[10]  Yuan Zhang,et al.  Irisin Promotes Human Umbilical Vein Endothelial Cell Proliferation through the ERK Signaling Pathway and Partly Suppresses High Glucose-Induced Apoptosis , 2014, PloS one.

[11]  Junxia Zhang,et al.  Circulating irisin levels are positively associated with endothelium-dependent vasodilation in newly diagnosed type 2 diabetic patients without clinical angiopathy. , 2014, Atherosclerosis.

[12]  Jing Zhao,et al.  An activator of mTOR inhibits oxLDL-induced autophagy and apoptosis in vascular endothelial cells and restricts atherosclerosis in apolipoprotein E-/- mice , 2014, Scientific Reports.

[13]  F. Soncin,et al.  miR126-5p repression of ALCAM and SetD5 in endothelial cells regulates leucocyte adhesion and transmigration. , 2014, Cardiovascular research.

[14]  F. Kiessling,et al.  MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1 , 2014, Nature Medicine.

[15]  Yuan Zhang,et al.  Irisin Stimulates Browning of White Adipocytes Through Mitogen-Activated Protein Kinase p38 MAP Kinase and ERK MAP Kinase Signaling , 2014, Diabetes.

[16]  S. Dimmeler,et al.  Vascular microRNAs: from disease mechanisms to therapeutic targets. , 2014, Circulation research.

[17]  Xinghui Sun,et al.  Endothelial MicroRNAs and Atherosclerosis , 2013, Current Atherosclerosis Reports.

[18]  Mary T. Brinkoetter,et al.  Circulating irisin in relation to insulin resistance and the metabolic syndrome. , 2013, The Journal of clinical endocrinology and metabolism.

[19]  A. Schober,et al.  MicroRNAs in flow-dependent vascular remodelling. , 2013, Cardiovascular research.

[20]  Jian-jun Liu,et al.  Lower circulating irisin is associated with type 2 diabetes mellitus. , 2013, Journal of diabetes and its complications.

[21]  M. Biffoni,et al.  miR-126&126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma , 2013, PloS one.

[22]  D. Amadori,et al.  miR-126 and miR-126* repress recruitment of mesenchymal stem cells and inflammatory monocytes to inhibit breast cancer metastasis , 2013, Nature Cell Biology.

[23]  B. Klapp,et al.  Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity – Correlation with body mass index , 2013, Peptides.

[24]  S. Samuel,et al.  The endothelium: influencing vascular smooth muscle in many ways. , 2012, Canadian journal of physiology and pharmacology.

[25]  Santiago Lamas,et al.  The non-canonical NOTCH ligand DLK1 exhibits a novel vascular role as a strong inhibitor of angiogenesis. , 2012, Cardiovascular research.

[26]  B. Spiegelman,et al.  A PGC1α-dependent myokine that drives browning of white fat and thermogenesis , 2012, Nature.

[27]  S. Peters,et al.  Improvements in risk stratification for the occurrence of cardiovascular disease by imaging subclinical atherosclerosis: a systematic review , 2011, Heart.

[28]  Maarten Hulsmans,et al.  MicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[29]  E. Olson,et al.  Pervasive roles of microRNAs in cardiovascular biology , 2011, Nature.

[30]  N. Suzuki,et al.  Resident Endothelial Cells Surrounding Damaged Arterial Endothelium Reendothelialize the Lesion , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[31]  RossellaMenghini,et al.  MicroRNA 217 Modulates Endothelial Cell Senescence via Silent Information Regulator 1 , 2009 .

[32]  G. Melino,et al.  MicroRNA 217 Modulates Endothelial Cell Senescence via Silent Information Regulator 1 , 2009, Circulation.

[33]  David Harrison,et al.  Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis. , 2009, American journal of physiology. Heart and circulatory physiology.

[34]  W. Min,et al.  Mechanisms of endothelial dysfunction, injury, and death. , 2009, Annual review of pathology.

[35]  Ru-Fang Yeh,et al.  miR-126 regulates angiogenic signaling and vascular integrity. , 2008, Developmental cell.

[36]  T. Rabelink,et al.  Endothelial function and dysfunction: testing and clinical relevance. , 2007, Circulation.

[37]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[38]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[39]  J. Hoying,et al.  Flow-Dependent Remodeling in the Carotid Artery of Fibroblast Growth Factor-2 Knockout Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[40]  A. Zeiher,et al.  Apoptosis of endothelial cells. Contribution to the pathophysiology of atherosclerosis? , 1999, European cytokine network.

[41]  Shingo,et al.  A PGC1-\(\alpha\)-dependent Myokine that Drives Brown-fat-like Development of White Fat and Thermogenesis , 2012 .

[42]  Aldons J. Lusis,et al.  Atherosclerosis : Vascular biology , 2000 .